Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
100.888,13
0,22%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Codexis Inc (CDXS) Codexis Inc (CDXS) Notizie

Codexis Inc

CDXS
4,3001
-0,1999 (-4,44%)
01 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/2/202501:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202500:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202523:04EDGAR2Form 8-K - Current report
16/1/202522:05GLOBECodexis Appoints Christos Richards to Board of Directors
10/1/202522:05GLOBECodexis Announces New Employment Inducement Grants
02/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:05GLOBECodexis Announces New Employment Inducement Grants
19/11/202422:05GLOBECodexis to Participate in Piper Sandler 36th Annual..
14/11/202422:53EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/11/202422:05GLOBECodexis Unveils Pioneering Enzymatic Synthesis Data to..
12/11/202422:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/11/202422:05GLOBECodexis Announces Appointment of Raymond De Vré, PhD, to..
12/11/202422:01EDGAR2Form 8-K - Current report
11/11/202422:05GLOBECodexis TIDES Europe Presentations to Feature Next Step in..
08/11/202422:05GLOBECodexis Announces New Employment Inducement Grants
04/11/202422:05GLOBECodexis to Participate in Upcoming Healthcare Conferences
31/10/202421:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202421:16EDGAR2Form 8-K - Current report
31/10/202421:05GLOBECodexis Reports Third Quarter 2024 Financial Results
28/10/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202422:05GLOBECodexis Announces Three siRNA Manufacturing Data..
22/10/202422:05GLOBEArtiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its..
22/10/202422:00EDGAR2Form 8-K - Current report
14/10/202413:05GLOBECodexis Announces New Employment Inducement Grants
11/10/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202400:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/10/202422:05GLOBECodexis to Report Third Quarter 2024 Financial Results on..
02/10/202422:30EDGAR2Form 8-K - Current report
02/10/202422:05GLOBECodexis Increases Cash Reserves and Enhances Management Team..
01/10/202413:05GLOBECodexis Licenses Genomics Life Science Enzyme Portfolio to..
26/9/202421:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202415:27EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
23/9/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202422:50EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/9/202422:05GLOBECodexis Announces New Employment Inducement Grants
03/9/202422:05GLOBECodexis to Participate in Upcoming Healthcare Conferences
20/8/202422:05GLOBECodexis to Participate in Enzymatic Synthesis Presentations..
16/8/202422:05GLOBECodexis Announces New Employment Inducement Grants
15/8/202422:05GLOBECodexis Publishes FY2023 Sustainability Disclosures
09/8/202422:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202422:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:07EDGAR2Form 8-K - Current report
08/8/202422:05GLOBECodexis Reports Second Quarter 2024 Financial Results
18/7/202422:05GLOBECodexis to Report Second Quarter 2024 Financial Results on..
12/7/202422:15EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
01/7/202422:05GLOBECodexis Finalizes Purchase Agreement with Crosswalk..
14/6/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 4,48 Min: 4,18 Max: 4,51
Chiusura: 4,50

La tua Cronologia

NASDAQ
CDXS
Codexis
NASDAQ
MNTX
Manitex
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci